De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary
Open Access
Abstract
The population with intellectual disabilities is one of the most vulnerable groups in society. Medication use is the main therapeutic intervention in this population and psychotropic medications can be prescribed for mental health conditions and for challenging behaviors. Clinical experience of prescribers and pharmacists working with people with intellectual disabilities suggests that reducing or stopping psychotropic medication is not always straightforward. What is required is rational, rather than rationed, prescribing of psychotropic medications. Concerns of clinicians working with people with intellectual disabilities and both formal and informal carers can result in maintenance of the ‘status quo.’ Setting-related, carer-related and staff-related factors play an important role in the real world of people with intellectual disabilities. Optimizing medication regimens in the adult population with intellectual disabilities is complicated but it is recognized that efforts to improve the current state of medication utilization are required for many individuals with intellectual disabilities. Pharmacists have a responsibility to include the person and/or their carer in their efforts to promote optimization of psychotropic medication use in environment in which the person lives.Keywords
This publication has 19 references indexed in Scilit:
- Building quality indicators for medication use in people aging with intellectual disabilities and behaviour disordersInternational Journal of Developmental Disabilities, 2016
- American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2015
- Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort studyBMJ, 2015
- Pharmacists’ medicines-related interventions for people with intellectual disabilities: a narrative reviewInternational Journal of Clinical Pharmacy, 2015
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 2Age and Ageing, 2014
- The Confidential Inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based studyThe Lancet, 2014
- The effects of training on the ability of adults with an intellectual disability to give informed consent to medicationJournal of Intellectual Disability Research, 2013
- Stress and burnout amongst professional carers of people with intellectual disability: another health inequityCurrent Opinion in Psychiatry, 2006
- Antipsychotic medication for challenging behaviour in people with learning disabilityCochrane Database of Systematic Reviews, 2004
- Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settingsJournal of Intellectual Disability Research, 1990